BRIDGEWATER, N.J.--(BUSINESS WIRE)--In view of the unusual market activity in the stock of CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), the NYSE has contacted CorMedix in accordance with its usual practice; CorMedix stated that its policy is not to comment on unusual market activity or rumors.
